forphenicinol has been researched along with Carcinoma, Squamous Cell in 1 studies
*Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckett, MA; Jaskowiak, NT; Kimchi, E; Kufe, DW; Lopez, CA; Mauceri, HJ; Mehta, N; Murphy, KT; Ohno, T; Posner, MC; Salloum, RM; Wardak, A; Weichselbaum, RR | 1 |
1 other study(ies) available for forphenicinol and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Drug Synergism; Female; Glycine; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Radiotherapy; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2005 |